Sandoz and Samsung Bioepis join forces to boost biosimilar market and enhance healthcare access
SOUTH KOREA — Novartis’ generic drugs division, Sandoz, has forged a strategic collaboration...
Read More
Tag: Samsung Bioepis
Drugmakers introduce cheaper alternatives to Humira, a blockbuster arthritis drug
USA — Drug manufacturers Organon and Samsung Bioepis have announced the launch of a lower-cost...
Read More
Samsung Biologics shells US$2.3 bln to complete acquisition of Samsung Bioepis
SOUTH KOREA – Samsung Biologics has completed the US$2.3 billion acquisition of Biogen’s...
Read More
LATEST DIGITAL MAGAZINE
